187 related articles for article (PubMed ID: 8889506)
1. Frequency and distribution of NF2 mutations in schwannomas.
Jacoby LB; MacCollin M; Barone R; Ramesh V; Gusella JF
Genes Chromosomes Cancer; 1996 Sep; 17(1):45-55. PubMed ID: 8889506
[TBL] [Abstract][Full Text] [Related]
2. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
4. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
5. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
6. Exon scanning for mutation of the NF2 gene in schwannomas.
Jacoby LB; MacCollin M; Louis DN; Mohney T; Rubio MP; Pulaski K; Trofatter JA; Kley N; Seizinger B; Ramesh V
Hum Mol Genet; 1994 Mar; 3(3):413-9. PubMed ID: 8012353
[TBL] [Abstract][Full Text] [Related]
7. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
8. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
[TBL] [Abstract][Full Text] [Related]
9. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
Cheng JQ; Lee WC; Klein MA; Cheng GZ; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 1999 Mar; 24(3):238-42. PubMed ID: 10451704
[TBL] [Abstract][Full Text] [Related]
10. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
[TBL] [Abstract][Full Text] [Related]
11. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
12. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
13. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mutations in the SCH gene in schwannomas.
Bijlsma EK; Merel P; Bosch DA; Westerveld A; Delattre O; Thomas G; Hulsebos TJ
Genes Chromosomes Cancer; 1994 Sep; 11(1):7-14. PubMed ID: 7529050
[TBL] [Abstract][Full Text] [Related]
15. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
16. Universal absence of merlin, but not other ERM family members, in schwannomas.
Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
[TBL] [Abstract][Full Text] [Related]
18. Functional inactivation of NF2/merlin in human mesothelioma.
Thurneysen C; Opitz I; Kurtz S; Weder W; Stahel RA; Felley-Bosco E
Lung Cancer; 2009 May; 64(2):140-7. PubMed ID: 18835652
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the neurofibromatosis 2 gene in human breast and hepatocellular carcinomas.
Kanai Y; Tsuda H; Oda T; Sakamoto M; Hirohashi S
Jpn J Clin Oncol; 1995 Feb; 25(1):1-4. PubMed ID: 7877257
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene.
Hara T; Bianchi AB; Seizinger BR; Kley N
Cancer Res; 1994 Jan; 54(2):330-5. PubMed ID: 7506121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
